G

ood morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that all-too-familiar routine of meetings, deadlines, and what-not has returned. You knew this would happen, yes? To cope, we are quaffing a delicious cup of stimulation — peppermint mocha is now in our rotation — and invite you to join us, as always. Meanwhile, here are some tidbits to further stimulate you. Hope you have a smashing day and, of course, do keep in touch. We enjoy your furtive notes …

Nevada prison officials are refusing a demand by Pfizer (PFE) to return a drug and not use it in a planned lethal injection execution, the Associated Press reports. Plans for Nevada’s first execution in more than a decade — using a never-before-tried combination of diazepam, fentanyl, and the muscle paralytic cisatracurium — were put on hold last week pending review by the state Supreme Court.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • May I observe this phrasing is …. bemusing? “The regulator has already indicated that moving to Amsterdam, Barcelona, Copenhagen, Milan, or Vienna would cause the least disruption,…”
    And if Catalonia goes back on the independence route and leaves the EU? Then another move would be in the offing – one might strike Barcelona as a likely candidate, mighten one?

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.